scholarly journals A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells

2015 ◽  
Vol 6 (10) ◽  
pp. e1944-e1944 ◽  
Author(s):  
W Mughal ◽  
L Nguyen ◽  
S Pustylnik ◽  
S C da Silva Rosa ◽  
S Piotrowski ◽  
...  
2007 ◽  
Vol 42 (6) ◽  
pp. S81-S82
Author(s):  
Cinzia Perrino ◽  
Giuseppe Gargiulo ◽  
Giuseppe Ambrosio ◽  
Rosalia Guerriero ◽  
Massimo Chiariello

Author(s):  
Charalambos Michaeloudes ◽  
Julia Frankenberg Garcia ◽  
Bingling Xu ◽  
Xia Li ◽  
Christopher Hui ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-15 ◽  
Author(s):  
Amy C. Keller ◽  
Leslie A. Knaub ◽  
P. Mason McClatchey ◽  
Chelsea A. Connon ◽  
Ron Bouchard ◽  
...  

Diabetes affects more than 330 million people worldwide and causes elevated cardiovascular disease risk. Mitochondria are critical for vascular function, generate cellular reactive oxygen species (ROS), and are perturbed by diabetes, representing a novel target for therapeutics. We hypothesized that adaptive mitochondrial plasticity in response to nutrient stress would be impaired in diabetes cellular physiology via a nitric oxide synthase- (NOS-) mediated decrease in mitochondrial function. Primary smooth muscle cells (SMCs) from aorta of the nonobese, insulin resistant rat diabetes model Goto-Kakizaki (GK) and the Wistar control rat were exposed to high glucose (25 mM). At baseline, significantly greater nitric oxide evolution, ROS production, and respiratory control ratio (RCR) were observed in GK SMCs. Upon exposure to high glucose, expression of phosphorylated eNOS, uncoupled respiration, and expression of mitochondrial complexes I, II, III, and V were significantly decreased in GK SMCs (p<0.05). Mitochondrial superoxide increased with high glucose in Wistar SMCs (p<0.05) with no change in the GK beyond elevated baseline concentrations. Baseline comparisons show persistent metabolic perturbations in a diabetes phenotype. Overall, nutrient stress in GK SMCs caused a persistent decline in eNOS and mitochondrial function and disrupted mitochondrial plasticity, illustrating eNOS and mitochondria as potential therapeutic targets.


2004 ◽  
Vol 67 (10) ◽  
pp. 1985-1995 ◽  
Author(s):  
Evgenia Alpert ◽  
Hamutal Altman ◽  
Hanan Totary ◽  
Arie Gruzman ◽  
Dana Barnea ◽  
...  

2013 ◽  
Vol 319 (3) ◽  
pp. 134-143 ◽  
Author(s):  
Matti Viitanen ◽  
Erik Sundström ◽  
Marc Baumann ◽  
Minna Poyhonen ◽  
Saara Tikka ◽  
...  

2012 ◽  
Vol 36 (5) ◽  
pp. 433-439 ◽  
Author(s):  
Kiyo Takeuchi ◽  
Koichi Yamamoto ◽  
Mitsuru Ohishi ◽  
Hikari Takeshita ◽  
Kazuhiro Hongyo ◽  
...  

Development ◽  
1998 ◽  
Vol 125 (22) ◽  
pp. 4565-4574 ◽  
Author(s):  
Q. Lin ◽  
J. Lu ◽  
H. Yanagisawa ◽  
R. Webb ◽  
G.E. Lyons ◽  
...  

The embryonic vasculature develops from endothelial cells that form a primitive vascular plexus which recruits smooth muscle cells to form the arterial and venous systems. The MADS-box transcription factor MEF2C is expressed in developing endothelial cells and smooth muscle cells (SMCs), as well as in surrounding mesenchyme, during embryogenesis. Targeted deletion of the mouse MEF2C gene resulted in severe vascular abnormalities and lethality in homozygous mutants by embryonic day 9.5. Endothelial cells were present and were able to differentiate, but failed to organize normally into a vascular plexus, and smooth muscle cells did not differentiate in MEF2C mutant embryos. These vascular defects resemble those in mice lacking the vascular-specific endothelial cell growth factor VEGF or its receptor Flt-1, both of which are expressed in MEF2C mutant embryos. These results reveal multiple roles for MEF2C in vascular development and suggest that MEF2-dependent target genes mediate endothelial cell organization and SMC differentiation.


Sign in / Sign up

Export Citation Format

Share Document